The Enterprise Value as of September 2024 (TTM) for Comera Life Sciences Holdings, Inc. (CMRA) is -913895.00

According to Comera Life Sciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -913895.00. This represents a change of -108.34% compared to the average of 10.96M of the last 4 quarters.

Comera Life Sciences Holdings, Inc. (CMRA) Historical Enterprise Value (quarterly & annually)

How has CMRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Comera Life Sciences Holdings, Inc. over the last ten years is 132.32M. The current -913895.00 Enterprise Value has changed -169.07% with respect to the historical average. Over the past ten years (40 quarters), CMRA's Enterprise Value was at its highest in in the September 2021 quarter at 191.57M. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Comera Life Sciences Holdings, Inc. (CMRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Comera Life Sciences Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Comera Life Sciences Holdings, Inc. (CMRA) Average Enterprise Value

How has CMRA Enterprise Value performed in the past?

The current Enterprise Value of Comera Life Sciences Holdings, Inc. (CMRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Comera Life Sciences Holdings, Inc. (CMRA) Enterprise Value vs. Peers

How is CMRA’s Enterprise Value compared to its peers?

Comera Life Sciences Holdings, Inc.’s Enterprise Value is less than SAB Biotherapeutics, Inc. (13.85M), less than Processa Pharmaceuticals, Inc. (-892575.00), greater than Fresh Tracks Therapeutics, Inc. (-6417884.00), less than Third Harmonic Bio, Inc. (274.63M), less than Indaptus Therapeutics, Inc. (8.12M), less than Rezolute, Inc. (282.08M), less than Tempest Therapeutics, Inc. (23.41M), less than Forte Biosciences, Inc. (1.13M), less than Genelux Corporation (81.72M), less than Dyadic International, Inc. (36.57M), less than Cingulate Inc. (11.02M), less than Monopar Therapeutics Inc. (9.09M), less than Shattuck Labs, Inc. (119.24M), less than C4 Therapeutics, Inc. (433.17M), less than Eliem Therapeutics, Inc. (328.19M), less than Prelude Therapeutics Incorporated (133.44M), less than Monte Rosa Therapeutics, Inc. (295.46M), less than Virax Biolabs Group Limited (9.01M), less than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-10569356.00), less than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (4.04M),

Build a custom stock screener for Comera Life Sciences Holdings, Inc. (CMRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Comera Life Sciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Comera Life Sciences Holdings, Inc. (CMRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Comera Life Sciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.